Home › Funds › Marshall Wace › ABVX
Marshall Wace position in ABVX
ABIVAX SA · Health Care
Latest position (Q4 2025)59.76K sh
Reported value held$8.06M
Portfolio Weight0.01%
First reportedQ4 2023
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2023 | 46.90K | $501.85K | New |
| Q3 2024 | 30.91K | $356.08K | New |
| Q1 2025 | 74.84K | $467.76K | New |
| Q3 2025 | 189.70K | $16.11M | New |
| Q4 2025 | 59.76K | $8.06M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding ABVX
- Citadel Advisors 4.24M sh · $565.52M · Q2 2026
- UBS Group AG 1.86M sh · $247.95M · Q2 2026
- Morgan Stanley 1.43M sh · $190.85M · Q2 2026
- Norges Bank Investment Management 1.10M sh · $146.59M · Q2 2026
- Bank of America Corp 971.44K sh · $129.45M · Q2 2026
- Goldman Sachs Group 792.71K sh · $105.64M · Q2 2026
- Janus Henderson Group 878.83K sh · $98.01M · Q1 2026
- Balyasny Asset Management 624.44K sh · $83.21M · Q2 2026
- BlackRock Inc 574.06K sh · $76.50M · Q2 2026
- Millennium Management 307.64K sh · $41.00M · Q2 2026
- Franklin Resources 299.75K sh · $39.95M · Q2 2026
- Principal Global Investors 257.68K sh · $34.34M · Q2 2026